Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

CereScan Partners with Denver Outlaws Professional Lacrosse Team
  • USA - English


News provided by

CereScan Corp.

Jul 08, 2015, 02:00 ET

Share this article

Share toX

Share this article

Share toX

Denver, CO (PRWEB) July 08, 2015 -- A unique partnership between a professional Lacrosse team and an advanced neurodiagnostic brain imaging company promises to bring education on concussions and traumatic brain injuries to the forefront. CereScan is one of the country’s leading providers of SPECT (Single Photon Emission Computed Tomography) and PET/CT (Positron Emission Tomography/Computed Tomography) brain imaging that provides functional information about how the brain is actually working. In the sports world, this is particularly important if a player has sustained one or several concussions. CereScan’s imaging process accurately detects what areas of the brain are affected and identifies a clear diagnosis for the patient’s condition.

CereScan Corp. is proud to partner with the Denver Outlaws Professional Lacrosse Team, not only on an organizational level, but on an ethical level as well. So often in professional sports, concussions and traumatic brain injuries are overlooked or downplayed in severity because it affects the player’s ability to perform. As a responsible partner, the Denver Outlaws have taken the initiative to connect with a scientifically-based healthcare company, such as CereScan, that has the diagnostic tools to help their professional athletes accurately identify the area of their brain that is affected by a previous concussion or traumatic brain injury. Once the injury or condition is identified, the player can work with their doctor to find a suitable treatment plan. In the media today, a lot more education and awareness is being shared about concussions and over time, this mindfully collaborative effort between these organizations will help eliminate the unfortunate stigma that follows a player after they sustain a concussion, either on or off the field.

CereScan’s CEO, John Kelley said, “To date we have worked with several patients who played professional football and one or two hockey players, but the fact that an entire professional Lacrosse team has taken an interest in what we do and are excited about what our advanced neurodiagnostic imaging can do for their players, is literally a game changer for concussion education and awareness. People do not have to live with the symptoms of a traumatic brain injury. I applaud the Denver Outlaws Professional Lacrosse Team and their organization for caring for their players’ brain health, in addition to their physical health.”

In 2013, the Outlaws had the greatest season in the history of Major League Lacrosse winning all 14 of their regular season games to become the first undefeated team in MLL history. This past season, the Outlaws followed up their historic 2013 campaign by capturing the franchise’s first MLL championship that earned them the Steinfeld Trophy!

According to the Federation of International Lacrosse, What began as stickball, a Native American Indian contest played by tribal warriors for training, recreation and religious reasons, has developed over the years into the interscholastic, professional and international sport of Lacrosse. The sport has officially earned the title of “America’s Fastest Growing Sport” over the last 10 years. According to the US Lacrosse League, the sport has grown by 77% since 2006. Spectators enjoy the fast paced mechanics of the game and marvel at the players’ strength and ability to be agile as they precisely throw the ball with ease across the field to a teammate or into the goal.

“It’s truly a revolutionary time in sports medicine to have a technology like CereScan available to meet the growing need of injured players to accurately diagnose brain injury. Our partnership with the Denver Outlaws will set a precedent that brain health is important and needs to be at the forefront for all professional sports leagues,” said CEO, John Kelley. Since 2009, patients from all over the country and throughout the world have consulted Denver-based CereScan and its leading physicians concerning chronic neurological and psychiatric issues including:

• Traumatic Brain Injury & Concussions
• Alzheimer’s Disease                     
• ADD/ADHD                                    
• Bipolar Disorder                                 
• Dementia
• Depression
• Toxic Brain Injury
• Parkinson’s Disease
• OCD
• Anxiety Disorder
• Learning Disorders

“The Denver Outlaws are excited to partner with CereScan Corporation for the 2015 professional Lacrosse season. CereScan is a progressive diagnostic brain imaging company that has the service capabilities and medical resources to provide our players, team physicians and coaching staff with tools and education needed to promote better brain health within our Lacrosse team. This is certainly a unique partnership, and we look forward to the positive impact this relationship will have on our organization,” said Ted Tsang, Director of Marketing for the Denver Outlaws.

About CereScan

CereScan combines state-of-the-art SPECT and PET/CT brain imaging technologies with a patient- centered model of care to provide the highest level of neurodiagnostics anywhere. Using quantitative functional brain imaging, advanced imaging software, and an extensive library of clinical data, the CereScan medical team provides physicians with unmatched objective diagnostic information. CereScan helps patients and their physicians better understand the neurological basis of their conditions. In a variety of legal settings, CereScan provides objective evidence to attorneys and their clients regarding traumatic and toxic brain injuries. For researchers, CereScan provides independent pre- and post-treatment measures of organic changes in the brain along with measures of symptoms related to the brain disorder of interest. For more information, please call (866) 722-4806 or visit http://www.cerescan.com.

About Denver Outlaws Professional Lacrosse Team

The Denver Outlaws are an organization committed to not only winning MLL championships but also to growing new lacrosse fans, making a positive impact on the community, and providing superior entertainment, value and service. Under the ownership and direction of Denver Broncos owner Pat Bowlen, the Denver Outlaws have established themselves as the model franchise in Major League Lacrosse, building a tradition of success and a loyal fan base since their inception in 2006. For more information about the Outlaws, log on to http://www.denveroutlaws.com.

John Kelley, CereScan Corp., http://www.cerescan.com, +1 720-259-1875, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.